Microemulsions of retinoids, and pharmaceutical compositions containing them

Details for Australian Patent Application No. 2004283432 (hide)

Owner Fidia Farmaceutici S.p.A.

Inventors Menegatti, Enea; Gennari, Giovanni; Esposito, Elisabetta; Bellato, Pierangelo; Cortesi, Rita

Agent Lord and Company

Pub. Number AU-B-2004283432

PCT Pub. Number WO2005/039532

Priority MI2003A002019 17.10.03 IT

Filing date 8 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 11 February 2010

International Classifications

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/07 (2006.01)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/039532 Priority application(s): WO2005/039532

11 February 2010 Application Accepted

  Published as AU-B-2004283432

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283436-Extended release pharmaceutical dosage form

2004283431-Transdermal pharmaceutical formulation for minimizing skin residues